Express News | Aethlon Medical Shares Are Trading Higher After the Company Received Ethics Committee Approval for Its Hemopurifier Clinical Trial in Cancer Patients With Solid Tumors Unresponsive to Anti-PD-1 Therapy

BenzingaJun 18 08:13 ET

Express News | Aethlon Medical Receives Full Ethics Approval for Hemopurifier Clinical Trial in Cancer Patients With Solid Tumors Unresponsive to Anti-PD-1 Therapy

BenzingaJun 18 08:05 ET

Express News | Aethlon Medical Inc: On June 13, Hrec of Central Adelaide Local Health Network Granted Full Ethics Approval for Co's Clinical Trial of Hemopurifier

ReutersJun 18 08:03 ET

Express News | Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial

ReutersJun 18 08:01 ET

(AEMD) - Analyzing Aethlon Medical's Short Interest

Aethlon Medical's (NYSE:AEMD) short percent of float has fallen 74.16% since its last report. The company recently reported that it has 453 thousand shares sold short, which is 8.97% of all regular sh

BenzingaJun 17 15:45 ET

12 Health Care Stocks Moving In Friday's Pre-Market Session

GainersAinos (NASDAQ:AIMD) stock rose 54.8% to $1.27 during Friday's pre-market session. The market value of their outstanding shares is at $8.2 million. Longeveron (NASDAQ:LGVN) shares moved upwards

BenzingaJun 14 08:06 ET